Mechanistic studies have shown that SLFN11 stabilizes RBM10 and promotes NUMB exon 9 skipping by inhibiting TRIM21-mediated RBM10 degradation, a process that is critical for regulating anti-tumor immune responses. This evidence concerns the gene SLFN11 and neoplasm.